Biomarker, Functional Status, and Quality-of-Life Trajectories Before Modes of Death in Heart Failure: Post - Scorecard - MDSpire

Biomarker, Functional Status, and Quality-of-Life Trajectories Before Modes of Death in Heart Failure: Post

  • By

  • Henri Lu

  • Annamaria Kosztin

  • Brian L. Claggett

  • Alberto Foà

  • Maria A. Pabón

  • Akshay S. Desai

  • Pardeep S. Jhund

  • Alasdair D. Henderson

  • Bela Merkely

  • Carolyn S. P. Lam

  • Michele Senni

  • Sanjiv J. Shah

  • Adriaan A. Voors

  • Faiez Zannad

  • Bertram Pitt

  • Flaviana Amarante

  • Riitta Saarinen

  • Yoriko De Sanctis

  • Andrea Glasauer

  • John J. V. McMurray

  • Muthiah Vaduganathan

  • Scott D. Solomon

  • June 1, 2026

  • 0 min

Share

Clinical Scorecard: Trajectories of Biomarkers, Functional Status, and Quality of Life Prior to Death in Heart Failure: A Post-Analysis

At a Glance

CategoryDetail
Condition
Key MechanismsBiomarkers, functional status, and quality of life measures preceding death (source needed).
Target Population
Care Setting

Key Highlights

  • Remove unsupported claims and ensure all highlights are directly referenced in the source.

Guideline-Based Recommendations

Diagnosis

    Management

    • E
    • n
    • s
    • u
    • r
    • e
    • a
    • l
    • l
    • m
    • a
    • n
    • a
    • g
    • e
    • m
    • e
    • n
    • t
    • s
    • t
    • r
    • a
    • t
    • e
    • g
    • i
    • e
    • s
    • a
    • r
    • e
    • e
    • x
    • p
    • l
    • i
    • c
    • i
    • t
    • l
    • y
    • s
    • t
    • a
    • t
    • e
    • d
    • i
    • n
    • t
    • h
    • e
    • s
    • o
    • u
    • r
    • c
    • e
    • .

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Patients with HF and LVEF ≥ 40%, aged 40 years or older.

        Finerenone showed efficacy and safety compared to placebo.

        Clinical Best Practices

        • R
        • e
        • m
        • o
        • v
        • e
        • u
        • n
        • s
        • u
        • p
        • p
        • o
        • r
        • t
        • e
        • d
        • p
        • r
        • a
        • c
        • t
        • i
        • c
        • e
        • s
        • .

        Related Resources & Content

        Original Source(s)

        Biomarker, Functional Status, and Quality-of-Life Trajectories Before Modes of Death in Heart Failure: Post

        • by Henri Lu, Annamaria Kosztin, Brian L. Claggett, Alberto Foà, Maria A. Pabón, Akshay S. Desai, Pardeep S. Jhund, Alasdair D. Henderson, Bela Merkely, Carolyn S. P. Lam, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Faiez Zannad, Bertram Pitt, Flaviana Amarante, Riitta Saarinen, Yoriko De Sanctis, Andrea Glasauer, John J. V. McMurray, Muthiah Vaduganathan, Scott D. Solomon

        • June 1, 2026

        Related Content

        Independent prognostic value of the triglyceride–glucose index and its incremental predictive contribution beyond traditional risk markers in acute heart failure: a retrospective cohort study

        Lung ultrasound B-lines, NT-proBNP, and left atrial volume Index for bedside characterization of preserved-ejection-fraction phenotype in acute heart failure: a single-center observational study

        Celiac Tied to Higher Transplant Rate

        Liver transplantation showed the strongest association, although absolute event rates remained low in a nationwide Swedish cohort study.